No Data
No Data
Johnson & Johnson's Options: A Look at What the Big Money Is Thinking
Companies Heavily Investing in AI Have Low Quant Valuation Grades
J&J Prostate Cancer Therapy Outperforms in Real-world Study
Johnson & Johnson Presents Results From Study Showing That ERLEADA Demonstrates Statistically Significant And Clinically Meaningful Improvement In Overall Survival Compared To Enzalutamide In Patients With Metastatic Castration-sensitive Prostate Cancer
Express News | J&J - Study in Mcspc Demonstrated That Erleada(®) Reduced Risk of Death by 23 Percent at 24 Months Compared to Enzalutamide
Express News | Erleada® (Apalutamide) Demonstrates Statistically Significant and Clinically Meaningful Improvement in Overall Survival Compared to Enzalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer
loading...
105251507 : u invest lot of stock .how much your investment?..mine just 23k
ひな☆彡 SOXL OP 105251507 : Forgot to post. Sorry man
SnowVested 105251507 : invested and sold, I believe, so that at a profit means you can buy more then you started with, but smart peeps in certain countries need to make a loss some times to 'even' out the books for tax time
ひな☆彡 SOXL OP SnowVested : Absolutely correct, like small capital cccount like me, we need to actively trade with things like SOXL or any direxions leverage ETF to maximise
101676347 : Salute..,🫡
View more comments...